Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	19.13B -15.9%
Revenue (ttm)	3.95B -22.4%
Net Income	254.82M +677.0%
EPS	0.54 +698.6%
Shares Out	478.36M
PE Ratio	74.24
Forward PE	45.57
Dividend	0.11 (0.27%)
Ex-Dividend Date	Jul 14, 2025

Volume	2,514,185
Average Volume	2,897,589
Open	40.02
Previous Close	40.00
Day's Range	39.50 - 40.49
52-Week Range	39.20 - 61.85
Beta	0.72
RSI	40.15
Earnings Date	Apr 23, 2026

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 3,860
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2025, SHA:688363's revenue was 4.20 billion, a decrease of -21.82% compared to the previous year's 5.37 billion. Earnings were 292.06 million, an increase of 67.59%.